SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stratajema who wrote (501)8/19/1997 1:14:00 PM
From: Cacaito   of 2173
 
Testing for HbA1c (glycosilated hemoglobin Adult type 1, which is formed during metabolic glucose derangements, and it is the regular HbA1 with glicoprotein formation due to excess glucose) and is an indicator of long term control or lack of control of diabetes disease.

HbA1c can not replace in any manner the daily and frequent glucose testing for usual insulin dosing changes.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext